SCHEMBL19953373

SCHEMBL19953373

O=C(O)CCCCCOc1cc(-c2cccs2)c(OCCCCCC(=O)O)cc1-c1cccs1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A9 P48067 5/20 0.49
▸ HPGD P15428 2/20 0.49
▸ NPC1 O15118 1/20 0.44
▸ PPARG P37231 2/20 0.43
▸ NCOA2 Q15596 1/20 0.43
▸ NCOA1 Q15788 1/20 0.43
▸ HIF1A Q16665 1/20 0.43
▸ FABP4 P15090 2/20 0.43
▸ LTB4R Q15722 5/20 0.41
▸ TSHR P16473 1/20 0.41
▸ FFAR1 O14842 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ CACNA1B Q00975 1/20 0.41
▸ APBA1 Q02410 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ PPARA Q07869 2/20 0.41
▸ PPARD Q03181 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19965192 0.86 PPARG (0.46) SLC6A9PPARGLTB4RMAPTPPARA
SCHEMBL4991638 0.76 HPGD (0.57) HPGDNPC1LTB4RTSHRALDH1A1
SCHEMBL11983239 0.75 SLC6A9 (0.43) SLC6A9NPC1KDM4EALDH1A1MAPT
SCHEMBL4989913 0.74 HPGD (0.54) HPGDNPC1LTB4RTSHRALDH1A1
SCHEMBL8148742 0.73 LMNA (0.62) HIF1AFABP4LTB4RALDH1A1MAPT
SCHEMBL8151680 0.73 LMNA (0.62) HIF1AFABP4LTB4RALDH1A1MAPT
SCHEMBL8158709 0.73 LMNA (0.62) HIF1AFABP4LTB4RALDH1A1MAPT
SCHEMBL8162525 0.73 LMNA (0.62) HIF1AFABP4LTB4RALDH1A1MAPT
SCHEMBL8161670 0.73 LMNA (0.62) HIF1AFABP4LTB4RALDH1A1MAPT
SCHEMBL8163174 0.73 LMNA (0.62) HIF1AFABP4LTB4RALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3510076-A1 CONDUCTING POLYMERS AND USES THEREOF Auckland UniServices Limited (NZ) 2019-07-17 — — EP disclosed
US-20190194386-A1 Conducting Polymers and Uses Thereof AUCKLAND UNISERVICES LIMITED (NZ) 2019-06-27 — — US disclosed
US-20190194386-A1 Conducting Polymers and Uses Thereof AUCKLAND UNISERVICES LIMITED (NZ) 2019-06-27 — — US disclosed
WO-2018047101-A1 CONDUCTING POLYMERS AND USES THEREOF AUCKLAND UNISERVICES LIMITED (NZ) 2018-03-15 — — WO disclosed
WO-2018047101-A1 CONDUCTING POLYMERS AND USES THEREOF AUCKLAND UNISERVICES LIMITED (NZ) 2018-03-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194386-A1 Conducting Polymers and Uses Thereof POLI, PARG, PARN SLC6A9 1810/4885HPGD 2858/4885NPC1 4213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback